SCHEMBL1419264

SCHEMBL1419264

C=NCCCNCCCCNCCCN

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.62
CA6 P23280 4/20 0.62
CA7 P43166 4/20 0.62
CA9 Q16790 4/20 0.62
CA14 Q9ULX7 4/20 0.62
CA5B Q9Y2D0 4/20 0.62
CA2 P00918 3/20 0.62
CA4 P22748 3/20 0.62
CA5A P35218 3/20 0.62
F13A1 P00488 2/20 0.62
CYP1A2 P05177 2/20 0.62
ALOX15 P16050 2/20 0.62
THPO P40225 2/20 0.62
CASP2 P42575 2/20 0.62
MEN1 O00255 2/20 0.62
RECQL P46063 2/20 0.62
KMT2A Q03164 2/20 0.62
CYP2C19 P33261 1/20 0.62
HSD17B10 Q99714 1/20 0.62
CA3 P07451 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Spermine SCHEMBL30446193 0.79 CA12 (1.00) CA12CA6CA7CA9CA14
SCHEMBL26132507 0.79 CA12 (1.00) CA12CA6CA7CA9CA14
Spermine SCHEMBL14965 0.79 CA12 (1.00) CA12CA6CA7CA9CA14
Spermine SCHEMBL288720 0.79 CA12 (1.00) CA12CA6CA7CA9CA14
Spermine SCHEMBL8514287 0.79 CA12 (1.00) CA12CA6CA7CA9CA14
SCHEMBL27941366 0.77
SCHEMBL12002491 0.76 CA12 (0.93) CA12CA6CA7CA9CA14
Spermine SCHEMBL8020847 0.76 CA12 (0.93) CA12CA6CA7CA9CA14
Spermine SCHEMBL6328887 0.76 CA12 (0.93) CA12CA6CA7CA9CA14
Spermine SCHEMBL1167355 0.76 UBE2N (1.00) CA12CA6CA7CA9CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112375772-A Construction method and application of plant expression vector suitable for sugarcane 广西壮族自治区农业科学院 2021-02-19 CN disclosed
EP-2298358-A1 Methods for delivery of nucleic acids Alnylam Pharmaceuticals Inc. (US) 2011-03-23 EP disclosed
EP-1549352-A2 METHODS FOR DELIVERY OF NUCLEIC ACIDS Nucleonics, Inc (US) 2005-07-06 EP disclosed
WO-2003093449-A2 METHODS FOR DELIVERY OF NUCLEIC ACIDS NUCLEONICS, INC. (US) 2003-11-13 WO disclosed